Approved indications:
Topical spinosad 0.9% is FDA-approved as a pediculicide for head lice infestations in adults and children 6 months and older and as a scabicide for scabies infestations in adults and children 4 years and older.

Off-label uses:
Clinicians may occasionally use spinosad off-label for other lice or mite infestations (for example, certain non–scalp lice or challenging scabies cases) when standard therapies are unsuitable, but evidence is limited and such use is typically guided by specialist judgment rather than large clinical trials.

Efficacy expectations – head lice:
In clinical trials, about 85% of patients were lice-free 14 days after one or two treatments, and many were cured with a single 10-minute application without mandatory nit combing; compared with permethrin 1% lotion, spinosad showed higher cure rates and often required fewer applications.

Efficacy expectations – scabies:
For scabies, a single full-body application left on for at least 6 hours produced high complete-cure rates around 70–80% by day 28 in trials, with marked reduction in lesions; itching and bumps may take several weeks to fully resolve even after the mites are killed, and direct head-to-head comparisons with permethrin or ivermectin are limited, but spinosad offers the convenience of a one-time, patient-directed treatment.

General use:
Topical spinosad 0.9% is for skin use only; it must not be swallowed or used in the eyes, mouth, or vagina, and hands should be washed after applying it, especially when treating someone else.

Head lice (adults and children 6 months and older):
Shake the bottle well, then apply enough suspension to completely cover the dry scalp, followed by all dry hair from roots to ends (up to one 120 mL bottle may be needed depending on hair length). Leave it on for 10 minutes, then rinse thoroughly with warm water; shampooing should generally be delayed for at least 24 hours. A second treatment is done only if live (crawling) lice are seen about 7 days after the first application.

Scabies (adults and children 4 years and older):
Shake the bottle well, then apply enough medicine to cover the entire body from the neck down to the soles of the feet, including skin folds, between fingers and toes, and under fingernails and toenails; balding patients should also treat the scalp, hairline, temples, and forehead. Allow it to soak in and dry for about 10 minutes before dressing, then leave it on the skin for at least 6 hours (often overnight) before bathing or showering; in most cases, only a single application is used unless a clinician recommends repeating it.

Special instructions:
Children should be treated only under direct adult supervision, and caregivers should avoid getting the product in the child’s eyes or mouth. For breastfeeding women, any product on the breast should be washed off with soap and water before nursing. All close contacts and the home environment (such as bedding, towels, and clothing) should be treated or cleaned according to professional guidance to prevent reinfestation.

Missed-dose guidance:
If a planned treatment day is missed, apply the medicine as soon as you remember, following the same directions; do not apply more than prescribed or repeat applications closer together than your clinician recommends. If the product was rinsed off earlier than the recommended 10 minutes (head lice) or 6 hours (scabies), contact your healthcare provider for advice on whether and when to reapply.

Overdose:
Using more than directed on the skin mainly increases the risk of local irritation; rinse off excess with water and seek medical advice if irritation is severe. If anyone swallows the product, call poison control (1-800-222-1222 in the U.S.) or seek emergency care immediately.

Common side effects:
Most people tolerate topical spinosad well; the most common effects are mild and temporary, including redness or irritation where it is applied, eye redness or irritation if it gets near the eyes for head-lice use, and with scabies treatment, mild application-site burning or stinging and dry skin in a small percentage of patients.

Serious or rare adverse effects:
Serious reactions are uncommon, but stop using the medicine and seek medical help right away if there is widespread rash, hives, severe itching or swelling beyond the treated area, trouble breathing, or signs of infection at treated sites; accidental swallowing, especially by a child, requires urgent evaluation or a call to poison control.

Warnings and precautions (age, pregnancy, breastfeeding, medical conditions):
Spinosad topical is not recommended for infants younger than 6 months because the product contains benzyl alcohol, which has been associated with serious toxicity in very young infants at high systemic exposures; for head lice it is approved from 6 months of age, and for scabies from 4 years of age. Systemic absorption of spinosad itself from intact skin is minimal, so it is generally considered reasonable to use in pregnancy if clearly needed. During breastfeeding, it is not expected to enter milk in meaningful amounts, but the benzyl alcohol in the vehicle can be absorbed through skin, so caregivers are advised to wipe the product off the breast with soap and water before nursing to avoid direct infant exposure. In people with severe skin breakdown, large areas of inflamed skin, or very low body weight, absorption of benzyl alcohol may be higher, so extra caution and medical supervision are advised; no specific dose changes are usually needed for kidney or liver disease because systemic exposure is negligible.

Overall safety compared with similar drugs:
Compared with older neurotoxic agents such as lindane and with malathion, topical spinosad has no detectable systemic absorption of the active ingredient, a low rate of mostly mild local reactions, and does not carry the same concerns for neurotoxicity or flammability; its main unique safety issue is the benzyl alcohol component, which restricts use in very young infants.

Reporting side effects and safety updates:
Patients and caregivers can report suspected side effects to the manufacturer (listed on the product carton) or to the FDA’s MedWatch program (online or at 1-800-FDA-1088), where updated safety information and warnings are also posted.

Drug and product interactions:
Because spinosad applied to the skin is not measurably absorbed into the bloodstream, clinically important interactions with oral or injected prescription drugs, OTC medicines, foods, or alcohol are not expected, and none are listed in standard prescribing information. However, using multiple topical insecticides, strong irritants (such as harsh medicated shampoos or peeling creams), or occlusive dressings on the same areas may increase irritation, so these combinations should be used only under professional guidance.

Supplements, foods, and alcohol:
There are no known interactions with vitamins, herbal supplements, or specific foods, and no dietary restrictions are required. Normal social alcohol use does not interact with topical spinosad, but it should never be swallowed or mixed with other products.

Precautions and conditions requiring extra care:
Avoid use in infants under 6 months because of the benzyl alcohol in the formulation. Use caution in people with extensive open sores, severely inflamed skin, or very thin or damaged skin, where absorption of benzyl alcohol could be higher. Anyone with a history of allergy to spinosad or any ingredient in the suspension should not use the product. Patients with very severe, crusted, or treatment-resistant scabies, or who are immunocompromised, may need additional or alternative systemic therapy as directed by a specialist.

Monitoring needs:
No routine blood tests, ECGs, or blood-pressure checks are required for typical use; monitoring is mainly clinical—checking for ongoing live lice or scabies lesions after treatment, watching for local skin irritation or allergy, and reassessing if symptoms persist or worsen.

Q: How quickly does spinosad start working on lice or scabies?
A: The medicine begins killing lice and scabies mites within hours of application, and many people see fewer live pests and less crawling or biting sensation by the next day, although itching and bumps—especially with scabies—can take several days to weeks to fully fade.

Q: Do I need to comb out nits after using spinosad for head lice?
A: Spinosad is both pediculicidal and ovicidal, so nit combing is not required for it to work, but using a fine-tooth comb can help remove dead lice and eggshells and makes it easier to confirm that the infestation is clearing.

Q: Can babies or young children use spinosad?
A: Spinosad topical suspension is approved for head lice in children 6 months and older and for scabies in children 4 years and older, and it should not be used in infants under 6 months because of the benzyl alcohol in the formulation.

Q: Is spinosad safe in pregnancy and while breastfeeding?
A: Because spinosad is not measurably absorbed through intact skin, it is generally considered reasonable to use in pregnancy if clearly needed, and during breastfeeding it is not expected to reach the baby through milk; however, any product on the breast should be washed off before nursing to avoid direct infant contact, and decisions should be made with your healthcare provider.

Q: How many treatments will I need?
A: Most people need only one treatment for head lice and one full-body treatment for scabies; a second head-lice treatment is recommended only if live lice are seen about 7 days later, and repeat scabies treatment is usually reserved for persistent or recurrent cases under medical supervision.

Q: Can I use spinosad on my pets or for household spraying?
A: The human prescription spinosad topical suspension is formulated and tested only for use on people’s skin and scalp, so it should not be used on animals or for environmental spraying; veterinarians can recommend appropriate pet treatments, and household cleaning for lice or scabies focuses on washing or heat-drying clothing, bedding, and towels.

Storage:
Store the bottle at room temperature 68–77°F (20–25°C) in a dry place, with short temperature excursions between 59–86°F (15–30°C) allowed, keep it tightly closed, and always keep it out of the reach of children.

Disposal:
If you have unused medicine, use a drug take-back program or ask your pharmacist how to dispose of it; do not pour large amounts down sinks or toilets, and you may place an empty, rinsed bottle in the household trash unless your local regulations advise otherwise.